In this free webinar, learn about current best practices for indication prioritization and common pitfalls. Attendees will gain insights into new clinical evaluation dimensions to improve assessments of clinical feasibility. The featured speaker will define ways of working across Commercial, R&D and RWE stakeholders to ensure appropriate assumptions relating to clinical strategies and plans are developed.
TORONTO, Ontario, Canada, March 22, 2023 /PRNewswire-PRWeb/ -- The direction of an asset coming out of discovery is the first key business decision organizations make toward ensuring that the asset will be differentiated and value-creating at launch. Oncology drugmakers today can expect to mount a sequence of indication launches over the lifecycle of their asset. As they do so, patients benefit from additional treatment options, and the research involved advances the understanding of these diseases. Yet, having multiple opportunities also tasks executives and researchers to set priorities and craft a well-defined approach to launch sequencing that is — at once —farsighted and sufficiently practical to leverage current marketplace opportunities.
But markets are changing at warp speed. There is a need to be more asset-focused and forward-looking when evaluating indication opportunities. More traditional methods of assessing indication opportunities are not forward-looking — nor are they asset-focused — and thus risk missing the mark.
With all that said, strategic decision-making can be improved by modest investments in developing prioritization criteria that are more specific to the asset and forward-looking.
This webinar will introduce a new and robust framework for indication prioritization that has resulted in more balanced and actionable assessments of individual indications by focusing not only on feasibility, but also on post-launch differentiation and value creation. Case studies will illustrate how this change in approach has improved decision-making and higher corporate valuations with less risk.
Register today to explore the different considerations for making better strategic decisions about indication prioritization.
Join Syneos Health and Xtalks for the live webinar on Tuesday, April 4, 2023, at 11am EDT (4pm BST/UK).
SPEAKERS:
Waynne Waterfield, Managing Director, Commercial Advisory, Syneos Health
Paul Borron, M.Sc., Ph.D., Senior Engagement Manager, Commercial Advisory Group, Consulting, Syneos Health
Naveen Murthy, Sr. Managing Director, Commercial Advisory Group, Consulting, Syneos Health
William Tam, Engagement Manager, Commercial Advisory Group, Consulting, Syneos Health
For more information, or to register for this event, visit Thinking Differently About Indication Prioritization: Considerations for Making Better Strategic Decisions.
ABOUT SYNEOS HEALTH
Syneos Health® (Nasdaq:SYNH) is a leading fully integrated biopharmaceutical solutions organization built to accelerate customer success. We translate unique clinical, medical affairs and commercial insights into outcomes to address modern market realities.
Together we share insights, use the latest technologies and apply advanced business practices to speed our customers' delivery of important therapies to patients. We support a diverse, equitable and inclusive culture.
To learn more about how we are Shortening the distance from lab to life®, visit syneoshealth.com or subscribe to our podcast.
ABOUT XTALKS
Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.
To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/
Contact:
Vera Kovacevic
Tel: +1 (416) 977-6555 x371
Email: [email protected]
Media Contact
Vera Kovacevic, Xtalks, +1 (416) 977-6555 x371, [email protected]
SOURCE Xtalks
Share this article